A synthetic peptide for use as a blocking control in assays to test for specificity of SMNDC1 antibody, Alternative Names: SMNDC1 control peptide, SMNDC1 antibody Blocking Peptide, Anti-SMNDC1 Blocking Peptide, Survival Motor Neuron Domain Containing 1 Blocking Peptide, SMNR Blocking Peptide, SPF30 Blocking Peptide, SMNDC1, SMNDC-1, SMNDC 1, SMNDC-1 Blocking Peptide, SMNDC 1 Blocking Peptide
SMNDC1
Reaktivität: Human
Wirt: Synthetic
BP, WB, IHC
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
SMNDC1
(Survival Motor Neuron Domain Containing 1 (SMNDC1))
Hintergrund
This gene is a paralog of SMN1 gene, which encodes the survival motor neuron protein, mutations in which are cause of autosomal recessive proximal spinal muscular atrophy. SMNDC1 is a nuclear protein that has been identified as a constituent of the spliceosome complex. This gene is differentially expressed, with abundant levels in skeletal muscle, and may share similar cellular function as the SMN1 gene. This gene is a paralog of SMN1 gene, which encodes the survival motor neuron protein, mutations in which are cause of autosomal recessive proximal spinal muscular atrophy.